An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
. Author manuscript; available in PMC: 2018 May 8.
Published in final edited form as: Nature. 2017 Nov 8;551(7679):192–197. doi: 10.1038/nature24638
Astrocytic Neuroligins Control Astrocyte Morphogenesis and Synaptogenesis
The publisher's version of this article is available at Nature
Abstract
Astrocytes are highly complex glial cells with numerous fine cellular processes which infiltrate the neuropil to interact with synapses. The mechanisms controlling the establishment of astrocytes’ remarkable morphology and how impairing astrocytic infiltration of the neuropil alters synaptic connectivity are largely unknown. Here we find that cortical astrocyte morphogenesis depends on direct contact with neuronal processes and occurs in tune with the growth and activity of synaptic circuits. Neuroligin (NL) family cell adhesion proteins, NL1, NL2, and NL3, which are expressed by cortical astrocytes, control astrocyte morphogenesis through interactions with neuronal neurexins. Furthermore, in the absence of astrocytic NL2, cortical excitatory synapse formation and function is diminished, whereas inhibitory synaptic function is enhanced. Our findings highlight a novel mechanism of action for NLs and link astrocyte morphogenesis to synaptogenesis. Because NL mutations are implicated in various neurological disorders, these findings also offer an astrocyte-based mechanism of neural pathology.
Astrocytes actively participate in synapse development and function by secreting instructive cues to neurons1. Through their perisynaptic processes, astrocytes maintain ion homeostasis, clear neurotransmitters2 and partake in neuromodulatory signaling to control circuit activity and behavior3. These complex functions of astrocytes are reflected in their elaborate structure4,5, which is driven by numerous fine processes that closely interact with synapses. Importantly, loss of astrocyte complexity is a common pathological feature observed in neurological disorders6.
Despite the vital roles astrocytes play in brain development and physiology, how their complex morphology is established is largely unknown. Furthermore, we do not know if disruptions in astrocyte morphogenesis lead to synaptic dysfunction. We investigated these questions in the developing mouse V1 visual cortex during postnatal days 1-21 (P1-P21), when astrocyte morphogenesis occurs concomitantly with synaptic development7,8. Using Aldh1L1-EGFP BAC-transgenic mice, in which all astrocytes express EGFP9, we found that astrocytic coverage of V1 neuropil profoundly increased from P7 to P21 (Fig. 1a-c), coinciding with high rates of synaptogenesis10. This increase correlated with the appearance of fine astrocytic processes (Extended Data Fig. 1a), and only became significant between P7-P14, coinciding with eye opening, suggesting that vision drives this growth (Fig. 1b). Indeed, dark rearing mice profoundly stunted astrocyte coverage of V1 but did not diminish coverage in the auditory cortex (Extended Data Fig. 1b-d)
Next, we investigated astrocyte growth at single cell level using Postnatal Astrocyte Labeling by Electroporation (PALE), which sparsely transfects and labels cortical astrocytes (Extended Data Fig. 1e-h). The volume of fluorescently-labeled astrocyte processes infiltrating the neuropil (neuropil infiltration volume (NIV)), dramatically increased between P7-P21 (Extended Data Fig. 1i-k). Dark rearing stunted NIV at P21, but not at P7 (Fig. 1d-e). V1 astrocytes also increased their territory size ~1.6-fold from P7 to P21 (Extended Data Fig. 1n-o). Intriguingly, astrocyte territories were significantly reduced by dark rearing at both ages (Extended Data Fig. 1p-q), suggesting that light-induced changes in V1, which occur even prior to eye opening11, play critical roles astrocyte territory growth. Altogether, our findings reveal that astrocyte morphogenesis occurs in tune with the growth and activity of the underlying synaptic circuits of the cortex.
To investigate the mechanisms linking astrocyte morphogenesis to neuronal circuit development, we established a primary rat cortical neuron-astrocyte co-culture system, which takes advantage of the observation that astrocyte complexity is greatly enhanced by co-culture with neurons compared to culturing them alone or on Cos7 cells (Extended Data Fig. 2a-e, h). Neuron-conditioned media was not sufficient to induce astrocyte elaboration (Extended Data Fig. 2e, h). Furthermore, inhibiting astrocyte glutamate sensing by blocking metabotropic glutamate receptor 5 (mGluR5) only slightly impaired astrocyte elaboration; whereas, blocking synaptic network activity by TTX did not diminish neuron-induced astrocyte elaboration (Extended Data Fig. 2f, i). These findings indicate that contact-mediated mechanisms, rather than secreted factors or synaptic activity, are the primary drivers for astrocyte morphogenesis in vitro. To test this, we methanol fixed neurons to preserve their structure, while eliminating dynamic feedback to astrocytes. Astrocytes fully elaborated by co-culture with methanol-fixed neurons, whereas, methanol-fixed Cos7 cells did not induce elaboration (Extended Data Fig. 2g, j-l). Extraction of neuronal structures by urea, while preserving the deposited extracellular matrix, severely stunted astrocyte elaboration (Extended Data Fig. 2g, j, m). Super-resolution imaging of astrocyte processes and synapses showed that astrocyte elaboration occurs near synapses, and astrocytes closely interact with synaptic structures in vitro (Extended Data Fig. 2n). Altogether, these results show that astrocyte morphogenesis is triggered by direct contact with neurons in vitro.
Astrocytes require NLs for complexity
Next, we mined gene expression databases12-14 to identify astrocytic cell adhesion molecules (CAMs) known to interact with neuronal and synaptic proteins. Intriguingly, astrocytes express three members of the NL family, NL1, NL2, and NL3, at levels comparable to, or higher than, neurons (Extended Data Fig. 3a-f). We confirmed that rodent astrocytes express NLs by fluorescent in situ hybridization in vivo and by RT-PCR and Western blotting in vitro (Extended Data Fig. 3g-j).
NLs have been overwhelmingly studied in the context of neurons15-17 with few exceptions18-20. Simultaneous knockdown of all astrocytic NLs with short hairpin RNAs (shRNA) (Extended Data Fig. 4a-c) completely blocked neuron-induced astrocyte elaboration in vitro (Fig. 2a-b). Silencing each individual astrocytic NL partially, but significantly diminished astrocyte arborization, indicating non-overlapping roles for each NL in astrocyte morphogenesis in vitro (Fig. 2a-e, Extended Data Fig. 4d). Co-transfection of shNLs with the corresponding RNA interference-resistant NL-cDNAs (Extended Data Fig. 4b-c and21) rescued astrocyte elaboration (Fig. 2a, c-e). NL-knockdown also inhibited astrocyte elaboration induced by co-culture with methanol-fixed neurons (Extended Data Fig. 4e-f). In contrast, knockdown of EphrinA3, a CAM with known roles in astrocyte-neuron interactions22, did not alter astrocyte morphogenesis (Extended Data Fig. 4g-h). Collectively, these results show that astrocytic NLs 1, 2, and 3 are required for the establishment of neuronal contact-induced astrocyte morphogenesis in vitro.
In neurons, NLs function by forming trans-synaptic adhesions with Neurexins (Nrxs)16. Swapping the extracellular cholinesterase (ChoE)-like domain of NL1 with the homologous cholinesterase sequence creates a chimera, NL1-SWAP, that is expressed and trafficked correctly, but cannot interact with presynaptic Nrxs23 (Extended Data Fig. 4i). Co-transfection of NL1-SWAP with shNL1 failed to rescue astrocyte morphogenesis (Fig 2f-g), even though shNL1 did not diminish NL1-SWAP expression, and NL1-SWAP alone in astrocytes did not impair astrocyte morphogenesis (Extended Data Fig. 4b, j-k). These results show that contacts mediated by the ChoE-like domain of NL1 are required for astrocyte morphogenesis and suggest that astrocytic NL-neuronal Nrx interactions regulate astrocyte development.
To test if neuronal Nrxs are required for astrocytic morphogenesis, we silenced Nrx expression in cultured rat neurons using a lentivirus encoding shRNAs against mouse Nrxs 1, 2, and 3 (both α- and β)24. In rat neurons, this lentivirus silenced Nrx1 and 2, but not Nrx3 due to mismatches between rat and mouse sequences (Extended Data Fig 5a-d). Silencing Nrx1/2 in neurons significantly diminished neuronal contact-induced astrocyte morphogenesis (Fig. 2h-i). Concurrently silencing NL1 in astrocytes did not further reduce astrocyte complexity (Extended Data Fig. 5e-g), indicating that Nrx1/2 are the primary neuronal interaction partners for astrocytic NL1. Additionally, these findings suggest that interactions between other astrocytic NL and neuronal Nrx pairs are also important for astrocyte morphogenesis in vitro.
Neuronal Nrx elimination may affect astrocyte morphology independent of the loss of Nrx-NL contacts. To overcome this caveat, we used methanol-fixed neurons to induce astrocyte morphogenesis and blocked Nrx/NL interactions by applying soluble Fc-tagged Nrx-β ectodomains (Extended Data Fig. 5h-j). Co-application of Nrx1/2/3β-Fc significantly diminished astrocyte complexity compared to Fc-only protein (Extended Data Fig. 5k-m). Application of Nrx1β-Fc or Nrx2β-Fc reduced astrocyte elaboration, but Nrx3β-Fc did not (Extended Data Fig. 5n). Meanwhile, silencing astrocytic NL1 did not further diminish astrocyte elaboration (Extended Data Fig. 5o). Next, we tested if trans-interactions with Nrxs are sufficient for astrocyte morphogenesis by coating 3D-nanofibers with Nrxβ-ectodomains to generate an artificial scaffold mimicking a web of neurites (Fig. 2j). Remarkably, all Nrxβ-coated nanofibers strongly induced astrocyte complexity compared to Fc-only (Fig. 2j-k). Together, these results show that interactions with neuronal Nrxs are required and sufficient for contact-induced astrocyte morphogenesis in vitro.
NLs control astrocyte morphology in vivo
To determine if NLs control astrocyte morphogenesis in vivo, we introduced EGFP-expressing shRNA plasmids targeting mouse NL1, NL2 or NL3 into V1 astrocytes by PALE. As a control, we used a scrambled NL1 shRNA sequence (shCtrl, Extended Data Fig. 6a-d). As expected, shCtrl-transfected astrocytes developed main branches by P7 and elaborated finer processes into the neuropil by P21 (Fig. 3a). NL1 knockdown dramatically stunted astrocytic NIV at P7, but this was corrected by P21. Conversely, NL3 knockdown did not alter astrocyte morphogenesis at P7, but severely arrested astrocyte growth by P21. Silencing NL2 restricted NIV at both time points (Fig. 3a-f, Extended Data Fig. 6e). These results show that NLs are required for astrocyte morphogenesis in vivo and suggest unique temporal roles for NLs in astrocyte development.
To determine how increasing NL expression alters astrocytic morphogenesis, we overexpressed NL1, NL2, NL3 or NL1-SWAP (control) in astrocytes by PALE. Astrocyte territories were dramatically enlarged by NL1 or NL2 overexpression compared to NL1-SWAP. NIV of NL1-overexpressing astrocytes did not change, whereas NIV slightly decreased for NL2-overexpressing astrocytes (Extended Data Fig. 6f-h). We were unable to find NL3-overexpressing astrocytes at P21, indicating that NL3-overexpression starting at P1 is not compatible with astrocyte survival and/or maturation. Altogether, these findings show that NL expression in astrocytes controls neuropil infiltration and territory size of these cells.
Astrocytic NL2 controls synaptogenesis
Because NL2 knockdown drastically impaired astrocyte morphogenesis at P7 and P21, we next investigated the specific in vivo functions of NL2 in astrocytes using the NL2-floxed mice25. To address the cell-autonomous effects of NL2 on astrocyte development, we sparsely deleted NL2 by introducing Cre via PALE in NL2(+/+) or NL2(f/+) or NL2(f/f) mice (NL2 PALE “WT” “HET” or “KO”, respectively). These mice also carried a single allele of the RTM (Ai14) transgene26 to label Cre positive (Cre+) cells with td-Tomato expression. NL2 expression in td-Tomato/Cre+ astrocytes was greatly diminished and using these mice and PALE, we confirmed the specificity and effectiveness of our shNL2 construct (Extended Data Fig. 7a-f). Similar to our results with shNL2 PALE experiments, deletion of NL2 in V1 L4 astrocytes decreased NIV. Loss of a single allele of NL2 (i.e. NL2 PALE “HET”) was sufficient to cause a partial, but significant decrease in astrocyte infiltration (Fig. 4a-b). Furthermore, loss of both NL2 alleles caused a significant reduction in territory size (Fig. 4c-d). Taken together, our results demonstrate an important function for NL2 in proper astrocyte morphogenesis in vivo.
Because astrocytes are critical controllers of excitatory and inhibitory synaptogenesis27, we next determined if astrocytic NL2 is required for proper synaptogenesis. We quantified the synapse density within the territories of NL2 PALE “HET” and “KO” L4 astrocytes in comparison to the density of synapses within the surrounding neuropil infiltrated by “WT” astrocytes (Fig. 4e). Synapses were labelled by the co-localization of pre- and postsynaptic markers (i.e. VGluT1/PSD95 (intracortical/excitatory), VGluT2/PSD95 (thalamocortical/excitatory) and VGAT/gephyrin (inhibitory). Co-localization of these markers reflects true synapses, since rotating the presynaptic channel 90° with respect to the postsynaptic channel eliminated most co-localization (Extended Data Fig. 8).
The density of excitatory synapses within the territory of NL2 PALE “KO” astrocytes were halved compared to the neighboring WT astrocytes; whereas losing a single allele of NL2 did not affect excitatory synapse density within its domain (Fig. 4f-i). GABAergic synapse density was not altered within the domains of NL2 PALE “HET” or “KO” astrocytes (Fig 4j-k). These results are quite surprising and distinct from the known neuronal roles of NL2 as regulators of inhibitory synapse formation28,29. We found that astrocytic NL2 is essential to locally regulate synapse development in a cell non-autonomous manner by controlling formation and/or maintenance of excitatory synapses within the territory of a given astrocyte.
Astrocytic NL2 controls synapse function
To determine how astrocytic NL2 affects the function of cortical synapses, we conditionally deleted NL2 (NL2 cKO) in a large population of astrocytes by combining the NL2 floxed allele containing the RTM transgene with the GLAST-CreERT2 mice30. Cre-recombination was activated by administering tamoxifen at P10 and P11 and monitored by td-tomato expression (Extended data Fig. 9a-b). NL2 (but neither NL1 nor NL3) mRNA was significantly reduced in td-Tomato/Cre+ astrocytes isolated from NL2 cKO cortices by fluorescence-activated cell sorting (FACS) compared to littermate NL2 conditional HETs. However, low levels of NL2 mRNA expression were detected likely due to incomplete recombination of both floxed alleles in some Cre+ astrocytes (Extended Data Fig. 9a-e). Importantly, GFAP was not different between NL2 cHET and cKO astrocytes (Extended Data Fig. 9e), indicating that NL2 cKO cells retained their astrocyte identity and did not undergo pathological reactivation characterized by enhanced GFAP expression6,31. Genotyping the sorted cells using allele-specific primers verified the recombination of the NL2 locus (Extended Data Fig. 9f-i). In V1 visual cortex 58.7±4.0% of the NL2 cHET or 53.9±4.4% of NL2 cKO astrocytes were td-Tomato/Cre+ and essentially all also expressed GFAP, indicating that Cre expression is restricted to astrocytes. Deletion of NL2 did not alter the number or distribution of astrocytes or neurons and the td-Tomato signal was absent from neurons within V1 cortex (Extended Data Fig. 10a-e).
We next performed whole-cell patch clamp recordings of miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs, respectively) in V1 L5 pyramidal neurons from P21 NL2 cHET and cKO mice (Extended Data Fig. 10f). L5 neurons possess large dendritic trees that project to all cortical layers and receive extensive excitatory and inhibitory synaptic inputs32. The frequency and amplitude of mEPSCs were significantly reduced in NL2 cKO neurons compared to cHETs (Fig. 5a-e). These observations are in accordance with our finding that loss of astrocytic NL2 locally decreases excitatory synapse numbers by 50%. Similarly, deleting NL2 in ~55% of the cortical astrocytes reduces the frequency of excitatory synaptic events by ~25%. Altogether our data show that astrocytic NL2 is required for the proper formation and function of excitatory synapses in the cortex.
Additionally, we detected an increase in the frequency of mIPSCs from the NL2 cKOs compared to cHETs while the amplitudes of mIPSCs were indistinguishable (Fig. 5f-j). The elevated frequency of mIPSCs in NL2 cKOs might be mediated by an increase in the number of inhibitory synapses. If so, loss of astrocytic NL2 more broadly should enhance inhibitory synaptogenesis. Alternatively, the increase in the frequency of mIPSCs might be due to changes in presynaptic release properties of inhibitory synapses. Taken together, these findings reveal a critical and previously unknown role for astrocytic NL2 as an essential governor of excitatory and inhibitory synaptic function in the cortex.
Here, we reveal several unknown cell biological aspects of astrocyte-neuron interactions that control the development of cortical astrocytes and demonstrate a critical function for astrocytic NLs in synaptogenesis. Bidirectional signaling via the astrocytic NL and neuronal Nrx adhesions might directly regulate synapse formation and function. Alternatively, astrocytic NLs might control synaptic connectivity by altering the expression and/or directed release of synaptogenic factors, such as thrombospondins, SPARCL1/Hevin and Glypicans33-35, from astrocytes. Future studies exploring the link between NL-mediated astrocyte-neuron adhesions and the regulation of astrocyte-induced synaptogenesis are necessary to test these possibilities.
Our findings also challenge the assumption that NLs are only functional within neurons of the brain. This is particularly important because gene mutations in NLs, including NL2, are associated with a number of neurological disorders such as autism and schizophrenia36,37. NL dysfunction in disease is postulated to alter the fine balance between inhibition and excitation in the brain38. Here we demonstrate that astrocytic NL2 controls the balance of excitatory and inhibitory synaptic connectivity, indicating that synaptic pathologies associated with NL mutations could originate from astrocytic dysfunction. Intriguingly, a recent study found that glial progenitor cells from schizophrenic patients express significantly lower levels of NL1, NL2, and NL3 compared to controls. When these human glial progenitors were injected into mice, they caused neuronal dysfunction, perturbed animal behavior and yielded abnormal astrocytic morphologies39. In conclusion, our findings reveal how imperative it is to understand the full extent of NL functions in all cell types of the brain to completely comprehend the pathophysiology of these disorders.
This work was supported by grants from the National Institutes of Health (RO1 DA031833 C.E., RO1 DE022743 R.R.J, F31 NS092419, J.A.S.) and Holland Trice Brain Research Award to (C.E.). K.T.B. was supported by Foerster-Bernstein Family and the Hartwell Foundation. We thank the NHLBI light microscopy core for STED imaging. We thank Drs. N. Allen, M. Bagnat, D. Silver and S. Soderling, for critical reading of the manuscript.
Footnotes
Data Availability
The data that support the findings of this study are included in the manuscript. Figures that include source data are figures 1-5 and extended data figures 1-10.
Supplementary Information is linked to the online version of the paper at www.nature.com/nature.
Author Contributions:
J.A.S. and C.E. designed the experiments and wrote the paper. All authors reviewed and edited the manuscript. J.A.S. performed experiments and analyzed data. J.A.S. and J.R. performed immunohistochemistry and cell/synapse count analysis. R-R.J. designed and D.L. and Y.K. performed and analyzed the electrophysiology experiments. J.A.S. and K.T.B. performed western blot analysis. J.A.S., E.E., and T.E. performed in vitro experiments and analysis.
Competing Financial Interests:
The authors declare no competing financial interests.
References
1.Clarke LE, Barres BA. Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci. 2013;14:311–321. doi: 10.1038/nrn3484. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Khakh BS, Sofroniew MV. Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci. 2015;18:942–952. doi: 10.1038/nn.4043. [DOI] [PMC free article] [PubMed] [Google Scholar]
3.Ma Z, Stork T, Bergles DE, Freeman MR. Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour. Nature. 2016;539:428–432. doi: 10.1038/nature20145. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Oberheim NA, et al. Uniquely hominid features of adult human astrocytes. J Neurosci. 2009;29:3276–3287. doi: 10.1523/JNEUROSCI.4707-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
5.Freeman MR. Specification and morphogenesis of astrocytes. Science. 2010;330:774–778. doi: 10.1126/science.1190928. [DOI] [PMC free article] [PubMed] [Google Scholar]
6.Burda JE, Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron. 2014;81:229–248. doi: 10.1016/j.neuron.2013.12.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Stichel CC, Muller CM, Zilles K. Distribution of glial fibrillary acidic protein and vimentin immunoreactivity during rat visual cortex development. J Neurocytol. 1991;20:97–108. doi: 10.1007/BF01279614. [DOI] [PubMed] [Google Scholar]
8.Morel L, Higashimori H, Tolman M, Yang Y. VGluT1+ neuronal glutamatergic signaling regulates postnatal developmental maturation of cortical protoplasmic astroglia. J Neurosci. 2014;34:10950–10962. doi: 10.1523/JNEUROSCI.1167-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
9.Cahoy JD, et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J Neurosci. 2008;28:264–278. doi: 10.1523/JNEUROSCI.4178-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Li M, et al. Synaptogenesis in the developing mouse visual cortex. Brain Res Bull. 2010;81:107–113. doi: 10.1016/j.brainresbull.2009.08.028. [DOI] [PubMed] [Google Scholar]
11.Akerman CJ, Smyth D, Thompson ID. Visual experience before eye-opening and the development of the retinogeniculate pathway. Neuron. 2002;36:869–879. doi: 10.1016/s0896-6273(02)01010-3. [DOI] [PubMed] [Google Scholar]
12.Srinivasan R, et al. New Transgenic Mouse Lines for Selectively Targeting Astrocytes and Studying Calcium Signals in Astrocyte Processes In Situ and In Vivo. Neuron. 2016;92:1181–1195. doi: 10.1016/j.neuron.2016.11.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
13.Zhang Y, et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci. 2014;34:11929–11947. doi: 10.1523/JNEUROSCI.1860-14.2014. [DOI] [PMC free article] [PubMed] [Google Scholar]
14.Zhang Y, et al. Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse. Neuron. 2016;89:37–53. doi: 10.1016/j.neuron.2015.11.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
15.Bemben MA, Shipman SL, Nicoll RA, Roche KW. The cellular and molecular landscape of neuroligins. Trends Neurosci. 2015;38:496–505. doi: 10.1016/j.tins.2015.06.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
25.Liang J, et al. Conditional neuroligin-2 knockout in adult medial prefrontal cortex links chronic changes in synaptic inhibition to cognitive impairments. Mol Psychiatry. 2015;20:850–859. doi: 10.1038/mp.2015.31. [DOI] [PubMed] [Google Scholar]
26.Madisen L, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133–140. doi: 10.1038/nn.2467. [DOI] [PMC free article] [PubMed] [Google Scholar]
28.Poulopoulos A, et al. Neuroligin 2 drives postsynaptic assembly at perisomatic inhibitory synapses through gephyrin and collybistin. Neuron. 2009;63:628–642. doi: 10.1016/j.neuron.2009.08.023. [DOI] [PubMed] [Google Scholar]
29.Varoqueaux F, et al. Neuroligins determine synapse maturation and function. Neuron. 2006;51:741–754. doi: 10.1016/j.neuron.2006.09.003. [DOI] [PubMed] [Google Scholar]
30.Wang Y, et al. Norrin/Frizzled4 signaling in retinal vascular development and blood brain barrier plasticity. Cell. 2012;151:1332–1344. doi: 10.1016/j.cell.2012.10.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
31.Liddelow SA, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481–487. doi: 10.1038/nature21029. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Allen NJ, et al. Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature. 2012;486:410–414. doi: 10.1038/nature11059. [DOI] [PMC free article] [PubMed] [Google Scholar]
34.Christopherson KS, et al. Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell. 2005;120:421–433. doi: 10.1016/j.cell.2004.12.020. [DOI] [PubMed] [Google Scholar]
35.Kucukdereli H, et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A. 2011;108:E440–449. doi: 10.1073/pnas.1104977108. [DOI] [PMC free article] [PubMed] [Google Scholar]
36.Singh SK, Eroglu C. Neuroligins provide molecular links between syndromic and nonsyndromic autism. Sci Signal. 2013;6:re4. doi: 10.1126/scisignal.2004102. [DOI] [PMC free article] [PubMed] [Google Scholar]
37.Sun C, et al. Identification and functional characterization of rare mutations of the neuroligin-2 gene (NLGN2) associated with schizophrenia. Hum Mol Genet. 2011;20:3042–3051. doi: 10.1093/hmg/ddr208. [DOI] [PMC free article] [PubMed] [Google Scholar]
38.Gao R, Penzes P. Common mechanisms of excitatory and inhibitory imbalance in schizophrenia and autism spectrum disorders. Curr Mol Med. 2015;15:146–167. doi: 10.2174/1566524015666150303003028. [DOI] [PMC free article] [PubMed] [Google Scholar]
39.Windrem MS, et al. Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia. Cell Stem Cell. 2017;21:195–208 e196. doi: 10.1016/j.stem.2017.06.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.